POU2F1通过上调PD-L1诱导肺癌免疫逃逸。

POU2F1 induces the immune escape in lung cancer by up-regulating PD-L1.

作者信息

Li Fei, Wang Tianyi, Huang Yinpeng

机构信息

The First Department of Thoracic Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute Shenyang 110042, China.

Health Management Center, The First Affiliated Hospital of Jinzhou Medical University Jinzhou 121000, China.

出版信息

Am J Transl Res. 2021 Feb 15;13(2):672-683. eCollection 2021.

DOI:
Abstract

PURPOSE

The aim was to research the POU2F1 related genes and mechanism during the progress of immune escape of lung cancer.

METHODS

Lung cancer cell lines (H1993, HCC827, A549, H2228, H3122 and H1975) and Human normal lung epithelial cell line (BEAS-2B) were involved in this study. Overexpression or knockdown of POU2F1 was processed in lung cancer cells. POU2F1, PD-L1 and CRK expression in cells were detected by WB and RT-PCR. Flow cytometry and immunofluorescence was used to detect PD-L1 expression on the cell surface. Luciferase reporter detected the promoter activity of CRK. C57BL/6 mice models with knocked down of of POU2F1 were constructed. After tumor formation, anti-PD-1 was administered to detect tumor suppressing ability. IHC assay showed the number of intratumoral CD3+, CD8+, GranzB+ T cells.

RESULTS

POU2F1 and PD-L1 were positively correlated in lung cancer cell lines. Overexpression of POU2F1 promoted the expression level of PD-L1 in lung cancer cells. POU2F1 transcription activated the expression of CRK, and further promoted the expression of PD-L1. Knockdown of POU2F1 promoted the efficacy of Anti-PD-1. In addition, tumor growth ability decreased after POU2F1 was knocked down. Cytotoxic effector cytokines levels, tumor suppressive chemokines and interleukin increased, while IL17a level decreased when POU2F1 was knocked down.

CONCLUSION

POU2F1 activates the expression of CRK, further promotes the expression of PD-L1, and finally improves the immune escape in lung cancer.

摘要

目的

研究肺癌免疫逃逸过程中POU2F1相关基因及机制。

方法

本研究纳入肺癌细胞系(H1993、HCC827、A549、H2228、H3122和H1975)及人正常肺上皮细胞系(BEAS-2B)。在肺癌细胞中进行POU2F1的过表达或敲低处理。通过蛋白质免疫印迹法(WB)和逆转录聚合酶链反应(RT-PCR)检测细胞中POU2F1、程序性死亡受体配体1(PD-L1)和CRK的表达。采用流式细胞术和免疫荧光法检测细胞表面PD-L1的表达。荧光素酶报告基因检测CRK的启动子活性。构建POU2F1敲低的C57BL/6小鼠模型。肿瘤形成后,给予抗程序性死亡蛋白1(PD-1)药物检测抑瘤能力。免疫组化分析显示肿瘤内CD3⁺、CD8⁺、颗粒酶B⁺T细胞数量。

结果

肺癌细胞系中POU2F1与PD-L1呈正相关。POU2F1过表达促进肺癌细胞中PD-L1的表达水平。POU2F1转录激活CRK的表达,进而促进PD-L1的表达。POU2F1敲低可提高抗PD-1的疗效。此外,POU2F1敲低后肿瘤生长能力下降。POU2F1敲低时,细胞毒性效应细胞因子水平、肿瘤抑制趋化因子和白细胞介素增加,而白细胞介素17a水平降低。

结论

POU2F1激活CRK的表达,进一步促进PD-L1的表达,最终促进肺癌的免疫逃逸。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索